AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05708326 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: 16/8 Method (intermittent fast regimen)
Description: Participants will have already followed the 16/8 Method (an intermittent fasting regimen) for a minimum of six days per week for a 90 day duration. This entailed limiting the eating hours to an 8-hour window, then fasting for the remaining 16 hours per day, with the last time of intake being 8pm.
Study NCT05424913 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: research-specific blood sample
Description: blood sample of 50 ml maximum levels of serum Insulin Regulated Amino Peptidase, lipidome markers and inflammation markers
Study NCT05115604 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cognitive behavioural intervention
Description: Six sessions of cognitive behavioural and psychoeducational therapy will be conducted to treat insomnia.
Study NCT04960202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07321332
Description: PF-07321332 (tablet)
Study NCT04766931 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FB2001
Description: Subjects will be administered with FB2001 by intravenous (IV) infusion
Study NCT04766931 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FB2001 Placebo
Description: Subjects will be administered with FB2001 placebo by intravenous (IV) infusion
Study NCT04960202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ritonavir
Description: Ritonavir (capsule)
Study NCT04960202 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo (tablet or capsule)
Study NCT05367180 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MISOLRE prevention program on sun risks
Description: Training of an ambassador class by a field coordinator Dissemination of the information by the ambassador class to the other classes of the school drawn by lot Transmission of an information document to parents on photoprotection to make them aware of the actions to adopt
Study NCT05367180 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vivre avec le Soleil prevention program on sun risks
Description: Program is delivered directly by the teachers through pedagogical books : 10 workshops over a period of 3 months
Study NCT05367180 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sun protection equipment
Description: Distribution of sunscreen, caps and sunglasses
Study NCT04929743 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BTI Implant
Description: Placement of dental implants of 5.5 vs >6.5 mm length
Study NCT04929743 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: BTI Implant
Description: Placement of dental implants of 5.5 vs >6.5 mm length
Study NCT04855266 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sucrose
Description: 5 mg/kg of intravenous iron sucrose (maximum dose of 200 mg). Iron sucrose will be diluted
Study NCT04855266 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Normal saline (NaCl 0.9%) 5 mL/kg (maximum volume 210 mL)
Study NCT04855266 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Tilt Table Test
Description: A table that adjusts the body position from horizontal to vertical to simulate standing up. Heart rate and blood pressure are monitored throughout the test.
Study NCT04855266 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: Tilt Table Test
Description: A table that adjusts the body position from horizontal to vertical to simulate standing up. Heart rate and blood pressure are monitored throughout the test.
Study NCT04905147 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mosapride
Description: Mosapride citrate is prokinetic drug that selectively activates 5-HT4receptors. Mosapride stimulates serotonin receptor in the digestive tract and increases acetylcholine release to promote upper digestive tract (stomach and duodenum) and lower digestive tract (colon) motility and gastric emptying without cardiac side effects
Study NCT04905147 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo drug 15 mg
Study NCT05336253 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EVERYbody Project-Connect
Description: 3-week dissonance-based, group, online body image program (4.5 hours total)
Study NCT05336253 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-Help Workbook
Description: Time-matched 3-week passive, individual workbook condition (4.5 hours total)
Study NCT06138340 — intervention group
Intervention type: DRUG
Intervention: Dexmedetomidine
Description: Participants will be sedated and maintained by dexmedetomidine during the surgery.
Study NCT06138340 — intervention group
Intervention type: DRUG
Intervention: Propofol
Description: Participants will be sedated and maintained by propofol during the surgery.
Study NCT05591820 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief behavioral parent training with optional booster sessions
Description: A brief and individually-tailored behavioral parent training program that combines stimulus control and contingency management techniques to treat children's behavioral difficulties in three (bi)weekly sessions and optional booster sessions.
Study NCT05591820 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Care as usual
Description: The care that is usually provided by the clinical institutions to treat children's behavioral difficulties. There are no restrictions regarding type or duration of CAU (only the brief parent training will not be allowed) which may for example include psychoeducation, (long) parent training, child treatment (e.g., pharmacotherapy, cognitive behavioral therapy) or family therapy.
Study NCT04722926 — intervention group
Intervention type: OTHER
Intervention: PJI
Description: patients having had a PJI managed at the CRIOAc Lyon, with or without relapse
Study NCT05226754 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diacerein
Description: After enrolment, patients will be randomized (n=20 group A) to receive diacerein capsules 50 mg every 12 hours for 10 days.
Study NCT05226754 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo capsules
Description: After enrolment, patients will be randomized (n=20 group A) to receive placebo capsules (lactose and magnesium stearate) every 12 hours for 10 days.
Study NCT05270785 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: STAT-PC
Description: STAT-PC is an adapted version of Suicidal Teens Accessing Treatment after an ED Visit (STAT-ED). It is a brief intervention based on motivational interviewing (MI) that focuses on mental health care seeking behavior, problem-solving, and referrals plus brief case management (2-3 follow-up calls). The intervention will consist of an initial session with the youth focusing on accessing mental health care plus two case management calls. The interventionist will also be available to assist with referrals for connection to other services later during the study period as needed for up to two months. The intervention may include contact with the youth's mental health provider to make sure linkages are made.
Study NCT05270785 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: YST-III
Description: YST-III is an adapted version of Youth-Nominated Support Team for Suicidal Adolescents (YST-II). The intervention is a brief intervention developed for youth who have been psychiatrically hospitalized due to a suicide attempt or suicidal ideation (SI). Participants will nominate 1-2 supportive adults (age 18 and older) from their lives who agree to provide ongoing contact and support for up to 2 months. YST-III will include an introductory session with the youth who will nominate their support persons plus referrals for mental health services. The support persons will receive training on how to best support their youth partner and then ongoing calls to support them in working with their youth partner for up to 2 months.
Study NCT06341153 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breast Milk Odor Stimulation
Description: In the breast milk odor stimulation group, one or two drops of breast milk were placed on a sponge in accordance with the literature. Breast milk was obtained from each infant's own mother by hand expressing. The mothers were asked to express two drops of breast milk from their breasts onto the sponge. The sponge on which the breast milk was dripped was placed as close to the baby's nose as possible without touching the baby's nose. Since breast milk odor stimulation is recommended to be given to the baby for 1 minute in the literature, the baby was allowed to smell the odor of breast milk for 1 minute. The baby was then given to the mother for breastfeeding and breastfeeding was initiated as in routine practice.
Study NCT06341153 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stimulation of Breast Milk Smell and Taste
Description: In this group in which the breast milk sniffing method was applied; two drops of breast milk were dripped onto a sponge in accordance with the literature and this sponge was placed as close to the nose as possible without touching the nose and the baby was allowed to smell the smell of breast milk for about 1 minute. Then the baby was given to the mother. The mother was asked to express milk manually and to apply/drip approximately 0.2 ml (approximately two drops) of the expressed colostrum starting from the tip of the baby's tongue, along the tongue surface, on both cheeks of the baby, as applied in studies using oral colostrum as a reference. The mother was also asked to express a drop of milk from her breast and manually apply it to the areola. Breastfeeding was then initiated as in routine practice.
Study NCT05267860 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Prophylactic Drain
Description: We want to put a prophylactic drain after cholecystectomy.
Study NCT05665088 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BXCL501
Description: Sublingual Film
Study NCT05665088 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Matching Placebo
Description: Sublingual Placebo Film
Study NCT05424003 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide Pen Injector
Description: Starting dose of 0.24 mg injected weekly and increased every 4 weeks to a potential maximum dose of 2.4 mg weekly at 20 weeks followed by 52 weeks of weekly injections at the maximum tolerable dose
Study NCT05424003 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo solution injected weekly for 72 weeks
Study NCT04242589 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiotherapy
Description: External beam radiation therapy is a type of radiation therapy used for cancer treatment. A machine is used to aim high-energy rays from outside the body into tumor
Study NCT04242589 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: External beam radiation therapy is a type of radiation therapy used for cancer treatment. A machine is used to aim high-energy rays from outside the body into tumor
Study NCT04242589 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Vertebropladty
Description: Vertebroplasty is a procedure for stabilizing compression fractures in the spine. Bone cement is injected into vertebrae that have cracked or broken. The cement hardens, stabilizing the fractures and supporting your spine.
Study NCT06419751 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Regular exercise
Description: Based on the study participant's status and exercise assessment, the investigators prescribe moderate-intensity aerobic exercise combined with resistance exercise. Before each exercise, preparatory activities (10min), 20-30min moderate-intensity aerobic exercise, finishing activities (10min) at the end, 5 days/week, for 12 weeks, and at the same time, choose non-consecutive 3 days of resistance training in 5 aerobic training sessions to increase resistance training (choose 1\~2 muscle groups each time, 4\~5 movements, repeat each action 8\~12 times, repeat 2\~3 sets)
Study NCT06419751 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Baduanjin
Description: A professional therapist instructed the participants to learn and train Baduanjin before the intervention, and a standardized Baduanjin exercise program included eight postures, each training time was about 50 minutes (including 10 min of warm-up, 2 times of Baduanjin, and 10 min of relaxation), 5 days/week, a total of 12 weeks
Study NCT05141123 — intervention group
Intervention type: PROCEDURE
Intervention: Complex Endovascular Aortic Procedures treated by Preloaded Fenestrated Stent-graft Designs for
Description: Evaluate the outcomes of the preloaded stent-graft design (PLD) in the routine treatment of para-renal and thoraco-abdominal aneurysms
Study NCT02776345 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound guided Needle Fragmentation
Description: Using 15-20 to and fro gentle movements of the needle tip, the calcification will be fragmented, with the needle tip within the pseudocapsule. The needle tip will be retracted into the subacromial bursa and 3 ml of 0.5% sensorcaine and 1 ml of steroid ( Depomedrol- 40mg/ml) will be injected into the bursa. The needle will then be removed.
Study NCT02776345 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: US guided needle fragmentation & Lavage
Description: Using local anesthetic and strict aseptic precautions, the tip of the 18-20 gauge needle will be advanced into the sub acromial bursa under ultrasound guidance and 2ml. of local anesthetic ( 1% xylocaine) will be injected into the bursa. The needle tip will be advanced into the supraspinatus tendon and ½ ml or less of 0.5% Sensorcaine will be injected into the pseudo capsule around the calcification. Using 15-20 to and fro gentle movements of the needle tip, the calcification will be fragmented, with the needle tip within the pseudo capsule. During this procedure, or after the fragmentation, using a syringe of saline or local anesthetic( 1% xylocaine) and with pumping action of the syringe the calcification with be sucked into the syringe.
Study NCT02776345 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Ultrasound guided subacromial injection
Description: Using local anesthetic and strict aseptic precautions, the tip of the 22 gauge needle will be advanced into the sub acromial bursa under ultrasound guidance and 4 ml. of local anesthetic ( 0.5% xylocaine) and 1 ml of steroid( Depomedrol 40 mg/ml) will be injected into the bursa. The needle will then be removed. Post procedure US images in the short and long axis planes will be obtained and documented. The patient's post procedure pain on a scale of 10 and their range of shoulder movement (abduction) will be assessed and documented.
Study NCT06026228 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Limosilactobacillus reuteri
Description: The BioGaia® Gastrus probiotic capsule contains the following components: L. reuteri DSM 17938, L. reuteri ATCC PTA 6475) at 10\^8 CFU\*/day, fully hydrogenated palm oil; ascorbic acid; tangerine flavour and mint flavour.~\*Colony forming Unit
Study NCT06026228 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo capsules have the same external appearance and composition as the BioGaia® Gastrus Limosilactobacillus reuteri probiotic capsule (combination of L. reuteri DSM 17938 and L. reuteri ATCC PTA 6475), but without the active ingredient.
Study NCT01189032 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DE-089 ophthalmic solution
Study NCT01189032 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo ophthalmic solution
Study NCT05282615 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Emanate Tray
Description: Emanate Tray, a personalized dental tray set (upper and lower) with PVA hydrogel containing 0.05% w/w chlorhexidine gluconate
Study NCT06223204 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Controlled euglycemia, hypoglycemia and hyperglycemia
Description: EIT measurements are collected in different glycemic states (euglycemia, hypoglycemia and hyperglycemia). Venous blood glucose is measured using a gold-standard glucose analyzer.
Study NCT05001854 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludrocortisone
Description: 100 μg every 6 hours of fludrocortisone per os
Study NCT05001854 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 100 μg every 6 hours of placebo per os
Study NCT05197751 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MSP3-CRM-Vac4All/ Alhydrogel®
Description: The Investigational Medicinal Product (IMP) or in short Investigational Product (IP) is the MSP3-CRM-Vac4All/ Alhydrogel® vaccine
Study NCT05987722 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enoxolone
Description: The experimental group returned home after the operation and used glycyrrhetinic acid toothpaste three times a day for oral cleaning.After the operation, toothpaste was used three times a day to clean the mouth for 12 weeks . Clinical evaluation was using the patient-reported pain score, painkillers, wound healing index (complete epithelization and color matching score), periodontal pocket depth, gingiva index, plaque index and were recorded before operation and 1st, 2nd, 3rd, 4th, 8th, 12th week after surgery. The control group used ordinary toothpaste for oral cleaning, and the rest of the research time, measurement time and measurement results were the same as the experimental group. During the study period, we will continue to monitor whether there is any adverse reaction, and if any adverse reaction occurs, the trial will be stopped.
Study NCT05987722 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sensodyne
Description: The Active Comparator group returned home after the operation and used glycyrrhetinic acid -free toothpaste(Sensodyne) three times a day for oral cleaning. After the operation, toothpaste was used three times a day to clean the mouth for 12 weeks . Clinical evaluation was using the patient-reported pain score, painkillers, wound healing index (complete epithelization and color matching score), periodontal pocket depth, gingiva index, plaque index and were recorded before operation and 1st, 2nd, 3rd, 4th, 8th, 12th week after surgery. The control group used ordinary toothpaste for oral cleaning, and the rest of the research time, measurement time and measurement results were the same as the experimental group. During the study period, we will continue to monitor whether there is any adverse reaction, and if any adverse reaction occurs, the trial will be stopped.
Study NCT06236529 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Behavior Change Counseling
Description: A telephone-based intervention employing principles and practices of motivational interviewing.
Study NCT06236529 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-management program
Description: An evidence-based 6-week SMP led by a registered nurse. The SMP was based on the Arthritis Self-Management Program and the Chronic Disease Self-Management Program.
Study NCT06236529 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-management program
Description: An evidence-based 6-week SMP led by a registered nurse. The SMP was based on the Arthritis Self-Management Program and the Chronic Disease Self-Management Program.
Study NCT05802758 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychopathy.comp and training in virtual reality (VR)
Description: Psychopathy.comp is a CFT-based manualized program of 20 sessions a 60 min, on a weekly basis. During the CFT-intervention, partipants try out their new skills in a tailored VR setting (x5)
Study NCT05283486 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MYMD-1 600MG
Description: Cohort 1: 600mg drug
Study NCT05283486 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MYMD-1 750mg
Description: Cohort 2: 750mg drug
Study NCT05283486 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MYMD-1 900mg
Description: Cohort 3: 900mg drug
Study NCT05283486 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: MYMD-1 1050mg
Description: Cohort 4: 1050mg drug
Study NCT05283486 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo 600mg
Description: Cohort 1: 600mg placebo
Study NCT05283486 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo 750mg
Description: Cohort 2: 750mg placebo
Study NCT05283486 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo 900mg
Description: Cohort 3: 900mg placebo
Study NCT05283486 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo 1050mg
Description: Cohort 4: 1050mg placebo
Study NCT05690100 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GeliO3
Description: Anti-inflammatory Gel which has a beneficial role on wound healing
Study NCT05690100 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gingi gel
Description: Anti-inflammatory Gel which has a beneficial role on wound healing
Study NCT04878731 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PF-06741086
Description: single dose SC injection of 300 mg PF-06741086
Study NCT05083338 — intervention group
Intervention type: PROCEDURE
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT05083338 — intervention group
Intervention type: PROCEDURE
Intervention: Pain Assessment
Description: Undergo pain assessment
Study NCT05083338 — intervention group
Intervention type: OTHER
Intervention: Questionnaire Administration
Description: Complete questionnaires
Study NCT06234254 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality headset with calming scenery
Description: Participants will be immersed in a virtual environment. Calming scenery will be shown via the headset for 20-30 minutes